EcoDrugPlus

Estrogen Receptor 2

Ensembl ID : ENSCDRG00005001039
Gene Symbol: ESR2
1 Cross references
274 Possible Orthologues:

Estrogen Related Receptor Gamma

Ensembl ID : ENSCDRG00005016328
Gene Symbol: ESRRG
3 Cross references
206 Possible Orthologues:

Exportin 1

Ensembl ID : ENSCDRG00005004581
Gene Symbol: XPO1
3 Cross references
296 Possible Orthologues:

Farnesyl Diphosphate Synthase

Ensembl ID : ENSCDRG00005008269
Gene Symbol: FDPS
3 Cross references
268 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSCDRG00005010723
Gene Symbol: FDFT1
3 Cross references
218 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSCDRG00005018946
Gene Symbol: FNTA
1 Cross references
222 Possible Orthologues:

Farnesyltransferase, Caax Box, Beta

Ensembl ID : ENSCDRG00005001508
Gene Symbol: FNTB
3 Cross references
211 Possible Orthologues:

Fatty Acid Amide Hydrolase

Ensembl ID : ENSCDRG00005019005
Gene Symbol: FAAH
3 Cross references
131 Possible Orthologues:

Fibroblast Activation Protein Alpha

Ensembl ID : ENSCDRG00005003579
Gene Symbol: FAP
3 Cross references
127 Possible Orthologues:

Fibroblast Growth Factor 2

Ensembl ID : ENSCDRG00005002828
Gene Symbol: FGF2
1 Cross references
88 Possible Orthologues:

Fibroblast Growth Factor Receptor 1

Ensembl ID : ENSCDRG00005013254
Gene Symbol: FGFR1
1 Cross references
293 Possible Orthologues:

Fibroblast Growth Factor Receptor 2

Ensembl ID : ENSCDRG00005014046
Gene Symbol: FGFR2
3 Cross references
216 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).